Point72 Asia »

Bicara Therapeutics shares owned by Point72 Asia

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Point72 Asia

Quarter filed Position value Share count Share price at filing
2024-09-30 $462k 18k 25.47

More positions owned by Point72 Asia

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Wells Fargo & Company (WFC)
Medtronic SHS (MDT)
Comcast Corp Cl A (CMCSA)
Danaher Corporation (DHR)
Spotify Technology S A SHS (SPOT)
Snowflake Cl A (SNOW)
Celestica (CLS)
Adobe Systems Incorporated (ADBE)

View all positions for Point72 Asia

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics